CITIGROUP INC

Position in TRVI — Trevi Therapeutics, Inc.

CIK 831001 NEW YORK, NY

Position in TRVI

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$1,192,391

-$353,803 QoQ

Shares Held

99,949

-19.1% QoQ

Ownership

0.070%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CITIGROUP INC holds $1,428,056,604 across 399 Biotechnology names. TRVI ranks #77 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	682,807	$304,900,636
2	REGN	Regeneron Pharmaceuticals, Inc.	184,691	$142,699,654
3	ALNY	Alnylam Pharmaceuticals, Inc.	263,375	$87,142,884
4	MRNA	Moderna, Inc.	1,480,034	$75,185,727
5	FOLD	AMICUS THERAPEUTICS, INC.	4,226,882	$61,120,713
6	BBIO	BridgeBio Pharma, Inc.	746,483	$55,433,827
7	INCY	Incyte Corp	489,649	$46,085,763
8	ROIV	Roivant Sciences Ltd.	1,536,110	$42,550,246

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,192,391	99,949	-19.1%	Shares	Defined	2026-05-11
2025-12-31	$1,546,194	123,498	+358.9%	Shares	Defined	2026-02-13
2025-09-30	$246,253	26,913	-57.9%	Shares	Defined	2025-11-10
2025-06-30	$349,854	63,959	+18.7%	Shares	Defined	2025-08-11
2025-03-31	$338,992	53,894	+12.6%	Shares	Defined	2025-05-12
2024-12-31	$197,165	47,856	+12.3%	Shares	Defined	2025-02-12
2024-09-30	$142,364	42,624	+228.2%	Shares	Defined	2024-11-12
2024-06-30	$38,700	12,987	+49.2%	Shares	Defined	2024-08-12
2024-03-31	$30,024	8,703	+25.1%	Shares	Defined	2024-05-10
2023-12-31	$9,320	6,956	+16076.7%	Shares	Defined	2024-02-09
2023-09-30	$92	43	-99.7%	Shares	Defined	2023-12-06
2023-06-30	$29,631	12,398	+629.3%	Shares	Defined	2023-08-10
2022-06-30	$4,777	1,700	—	Shares	Defined	2022-08-10
No filing history on record for this holder in this stock.